Core Insights - The establishment of the Zhongguancun (Changping) Brain Science and Brain-Computer Interface Industrial Cluster marks a significant step in developing a new industrial landscape in Changping District, Beijing [1] Group 1: Industrial Development Strategy - The "One Core, One City" strategy aims to leverage the Zhongguancun Life Science Park's core role to accelerate enterprise incubation and result transformation, forming an industrial cluster [2] - The plan includes the construction of an International Medical Device City to facilitate industrialization and establish a high-end manufacturing base [2] - The Changping Brain Science and Brain-Computer Interface Innovation Partnership Program will enhance foundational research, technological breakthroughs, and integrated innovation [2] Group 2: Policy and Financial Support - Chang Development Group and Daoyuan Capital have launched a strategic fund to inject financial resources into the brain science and brain-computer interface industry [2] - The district has introduced the first action plan for the development of the brain science and brain-computer interface industry, along with supporting policy measures [3] Group 3: Advantages and Growth Potential - Beijing's policy framework, innovation research, and talent aggregation provide a strong foundation for the brain science and brain-computer interface industry [3] - By 2027, the industrial cluster is expected to reach a certain scale, with a goal of forming a new billion-level future industry cluster by 2030 [4] Group 4: Industry Ecosystem and Collaboration - The region has attracted key enterprises and established a comprehensive ecosystem involving research institutions and clinical practices [5][6] - Notable achievements include the successful transformation of "Beijing Brain No. 1" and the filling of a gap in high-performance invasive brain-computer interfaces with "Beijing Brain No. 2" [6]

中新网北京9月29日电(记者 赵方园)9月28日，北京市脑科学与脑机接口产业创新发展工作推进会在昌平 生命谷国际精准医学产业园举办。会上，北京市首个脑科学与脑机接口产业集聚区在昌平挂牌、首个脑 科学与脑机接口产业园正式揭牌启用。 昌平生命谷国际精准医学产业园(供图) 2025年8月，七部门联合印发的《关于推动脑机接口产业创新发展的实施意见》对外发布，2025年1月， 北京市科学技术委员会、中关村科技园区管理委员会，北京市经济和信息化局联合印发了《加快北京市 脑机接口创新发展行动方案(2025-2030年)》，对加快发展脑机接口产业均作出系列重要部署。北京在脑 科学与脑机接口的政策布局、创新研发、人才汇聚上三重优势叠加，具有巨大的发展潜力。 相关负责人表示，未来，昌平区将加紧推进脑科学与脑机接口技术创新与产业应用，尽快做大做强脑科 学与脑机接口产业，不断塑造发展新动能新优势，打造脑科学与脑机接口创新策源地与产业引领区。 (完) 中新网记者现场了解到，中关村(昌平)脑科学与脑机接口产业集聚区将着力构建"一核一城"的产业格 局："一核"即发挥中关村生命科学园的引领作用，依托其创新资源与要素集聚优势，加快企业孵化和成 ...

中国青年报客户端讯（中青报·中青网记者 张敏）9月28日，北京市首个中关村（昌平）脑科学与脑机接 口产业集聚区和中关村（昌平）脑科学与脑机接口产业园正式揭牌启用。昌平区也推出北京市首个脑科 学与脑机接口产业发展行动计划及配套政策措施。 2025年7月，国家七部委联合印发《关于推动脑机接口产业创新发展的实施意见》，2025年1月北京市科 委、经信局联合印发《加快北京市脑机接口创新发展行动方案（2025-2030年）》，对加快发展脑机接 口产业均作出系列重要部署。北京在脑科学与脑机接口的政策布局、创新研发、人才汇聚上三重优势叠 加，具有巨大的发展潜力。 按照本次昌平区出台的配套政策，计划到2027年，产业集聚区初具规模，推动一批新技术、新产品、新 模式在多场景落地应用。到2030年，产业集聚区全面建成，产业创新能力和综合实力迈入国际一流行 列，力争形成一个新的百亿级未来产业集群。 为推动计划有序实施，昌平区从支持技术创新突破、支持企业集群发展、支持产业生态构建等三大方面 提出政策措施，将综合采取项目征集、招投联动、拨投结合等方式，支持各类创新主体加快落地，构 建"园区+投资+孵化+临床"四位一体服务体系，营造"拎 ...

Core Insights - Beijing is establishing a new industrial pattern for brain science and brain-computer interface (BCI) industries, with the unveiling of the Zhongguancun (Changping) BCI industrial cluster and park [1][2] - The Changping district is focusing on innovation-driven development, financial empowerment, and ecological construction to enhance the BCI industry [2][4] - By 2030, the goal is to create a new hundred-billion-level future industry cluster in the BCI sector [3][4] Group 1: Industrial Development - The Zhongguancun (Changping) BCI industrial cluster aims to leverage the core role of the Zhongguancun Life Science Park to accelerate enterprise incubation and result transformation [1][3] - The Changping district is initiating the BCI Innovation Partnership Plan to strengthen basic research, technological breakthroughs, and integrated innovation [2][4] - The district has already attracted 22 key BCI enterprises, indicating a growing industrial cluster effect [5] Group 2: Policy and Support Measures - Changping has introduced a comprehensive action plan and supporting policies for BCI industry development, focusing on technology innovation, enterprise cluster development, and industrial ecosystem construction [3][4] - The district plans to create a "park + investment + incubation + clinical" service system to support various innovation entities [4] - A strategic partnership has been formed between Chang Development Group and Daoyuan Capital to inject financial resources into the BCI industry [2][4] Group 3: Research and Clinical Applications - Changping is home to national-level research institutions and top medical facilities, providing a robust ecosystem for research and clinical applications in BCI technology [4][5] - The district has seen significant technological achievements, with two major BCI breakthroughs recognized at the 2025 Zhongguancun Forum [5] - The presence of over one million square meters of high-standard industrial space supports the full chain of research, pilot testing, and industrialization [4]

Core Viewpoint - The Sichuan Provincial Government has issued an implementation plan for the development and expansion of emerging industries, focusing on breakthroughs in original technology and the cultivation of future industries from 2025 to 2027 [1] Group 1: Technological Focus - The plan emphasizes innovation in brain science and brain-machine interface technology, aiming to strengthen the collection and processing of neural signals, as well as the assessment and regulation of brain states [1] - It aims to create a source of original technology by promoting the development of high-end equipment products such as brain-machine interface products, surgical robots, and rehabilitation robots with independent intellectual property rights [1] Group 2: Industry Development - Leading enterprises are encouraged to strategically position themselves for advancements in brain-like intelligence and accelerate the research and development of software products [1] - The plan includes the promotion of intelligent diagnostic and therapeutic technologies for neuropsychiatric disorders and brain impact-assisted rehabilitation technologies [1] Group 3: Application and Promotion - The government will select and publish a list of typical application scenarios and recommended directories to encourage the creation of differentiated and characteristic benchmark demonstration scenarios [1] - High-level matchmaking activities will be organized to accelerate the promotion of new technologies and products based on these scenarios [1]

Core Insights - The Beijing Brain Science and Brain-like Research Institute is making significant advancements in brain-machine interface (BMI) technology, which is crucial for improving the quality of life for patients with severe neurological conditions [2][4][6] - The institute has developed the "North Brain No. 1" system, which is the first high-throughput, wireless, fully implanted BMI system with over 100 channels, and it has entered clinical verification stages [2][4] - The research focuses on four main areas: brain cognitive principles, major brain diseases, new technologies in neuroscience, and neural decoding and computation [6][7] Group 1: Brain-Machine Interface Developments - The "North Brain No. 1" system allows for real-time decoding of brain signals, enabling patients to control devices through thought, with a notable accuracy of 63% in decoding common phrases for patients with speech impairments [3][4] - The institute has successfully completed surgeries for five patients with spinal cord injuries and ALS, demonstrating significant improvements in motor functions and the ability to perform tasks previously impossible [3][4] - The upcoming "North Brain No. 2" system aims to implant electrodes deeper into brain tissue for more precise signal capture, enhancing the control capabilities for patients [4] Group 2: Gene Therapy Innovations - The institute is also pioneering gene therapy techniques to treat conditions such as severe epilepsy and vision loss, with a new drug that can be injected directly into the epilepsy focus area to control seizures while preserving normal neural function [7] - A novel light-sensitive protein has been developed for visual restoration in patients with retinal diseases, showing significant improvements in vision for treated patients [6][7] - The institute has established a biotechnology company to facilitate the transition from basic research to clinical applications, aiming to shorten the time for technology commercialization [7]